Cargando…
Nebulized Lidocaine in COVID-19, An Hypothesis
Coronavirus Diseases-2019 (COVID-19) has caused a large global outbreak and has been declared as a pandemic by the World Health Organization (WHO). It has been proposed that COVID-19-related hyperinflammation and dysregulated immune response might play a critical role in developing a cytokine storm...
Autores principales: | Ali, Ziad A., El-Mallakh, Rif S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Eden Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833589/ https://www.ncbi.nlm.nih.gov/pubmed/32505070 http://dx.doi.org/10.1016/j.mehy.2020.109947 |
Ejemplares similares
-
Antidepressant discontinuation in treatment resistant depression
por: Ali, Ziad A., et al.
Publicado: (2019) -
Management of bipolar I depression: clinical utility of lurasidone
por: Findlay, Lillian Jan, et al.
Publicado: (2015) -
Transdermal Asenapine in Schizophrenia: A Systematic Review
por: Carrithers, Brennan, et al.
Publicado: (2020) -
Clinical effects and pharmacokinetics of nebulized lidocaine in healthy horses
por: Minuto, Jillian, et al.
Publicado: (2022) -
Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures
por: Brown, Martin E, et al.
Publicado: (2010)